Detalhe da pesquisa
1.
Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition.
Int J Biol Sci
; 19(1): 1-12, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36594099
2.
Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?
Front Mol Biosci
; 9: 1070383, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36699696
3.
Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression.
Cell Oncol (Dordr)
; 45(1): 135-149, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064910
4.
Downregulation of m6 A writer complex member METTL14 in bladder urothelial carcinoma suppresses tumor aggressiveness.
Mol Oncol
; 16(9): 1841-1856, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35048498
5.
Detailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategies.
Clin Transl Immunology
; 11(9): e1402, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36092481